Joseph E. Dohar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Joseph E. Dohar has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Edwin C. Klein
Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA
2 shared publicationsJean L. Betsch
Department of Pediatric Otolaryngology, Children's Hospital of Pittsburgh, Pittsburgh, PA 15213, USA
2 shared publicationsEric T. Garner
1 shared publicationMerril A. Biel
1 shared publicationMindell Seidlin
1 shared publicationPatricia A. Hebda
Department of Otolaryngology, Dermatology and Cell Biology, University of Pittsburgh School of Medicine and Children's Hospital of Pittsburgh, Pittsburgh, PA 15213, USA
1 shared publication
Latest Publications
- Open Access
- 1 May 1999
- Published by American Medical Association (AMA) in JAMA Otolaryngology–Head & Neck Surgery
- Vol. 125 (5) , 537-545
Topical Ofloxacin Treatment of Otorrhea in Children With Tympanostomy Tubes
BY CURRENT estimates, approximately 1 million children undergo tympanostomy tube insertions each year in the United States for the treatment of intractable middle ear effusions or repeated episodes of acute otitis media (AOM).1 Otorrhea occurs in 21% to 34% of all such children at some time after the tubes are in place.2 Unlike patients with AOM and intact tympanic membranes, children with tympanostomy tubes seldom have otalgia, fever, or other systemic signs of AOM without also having infections at other sites. Acute purulent otorrhea (draining ear) is the hallmark of AOM in the presence of tympanostomy tubes.
- 1 May 1999
- Published by American Medical Association (AMA) in JAMA Otolaryngology–Head & Neck Surgery
- Vol. 125 (5) , 537-545
Open AccessTopical Ofloxacin Treatment of Otorrhea in Children With Tympanostomy Tubes
BY CURRENT estimates, approximately 1 million children undergo tympanostomy tube insertions each year in the United States for the treatment of intractable middle ear effusions or repeated episodes of acute otitis media (AOM).1 Otorrhea occurs in 21% to 34% of all such children at some time after the tubes are in place.2 Unlike patients with AOM and intact tympanic membranes, children with tympanostomy tubes seldom have otalgia, fever, or other systemic signs of AOM without also having infections at other sites. Acute purulent otorrhea (draining ear) is the hallmark of AOM in the presence of tympanostomy tubes.
- 1 December 1998
- Published by Elsevier in International Journal of Pediatric Otorhinolaryngology
- Vol. 46 (3) , 159-170
Acquired subglottic stenosis—depth and not extent of the insult is key
- 1 December 1998
- Published by Elsevier in International Journal of Pediatric Otorhinolaryngology
- Vol. 46 (3) , 159-170
Acquired subglottic stenosis—depth and not extent of the insult is key
- Open Access
- 1 January 1998
- Published by American Medical Association (AMA) in JAMA Otolaryngology–Head & Neck Surgery
- Vol. 124 (1) , 25-29
Fetal Airway Wound Repair
SCARRING IS an important medical problem that may lead to poor cosmesis, structure, function, and growth. Otology, laryngology, and bronchoesophagology all have mucosa as their primary building block. Aberrant mucosal wound healing in the middle ear results in conductive hearing loss, eustachian tube dysfunction, adhesive otitis media, tympanosclerosis, and other abnormalities. In the airway, the consequences of scarring are potentially more devastating. The development of nasal, nasopharyngeal, laryngotracheal, and esophageal stenosis may be life threatening. Subglottic stenosis in children, for example, has become increasingly prevalent during the past quarter century because of widespread use of prolonged endotracheal intubation for respiratory support.1 Mortality rates as high as 24%, directly attributable to the tracheostomy in these children, have been reported.2 Not life threatening but, nonetheless, a priority to otolaryngologists are the perturbations in speech and communication caused by laryngeal scarring. Prevention or reduction of scarring remains a major goal of otolaryngologists.
- 1 January 1998
- Published by American Medical Association (AMA) in JAMA Otolaryngology–Head & Neck Surgery
- Vol. 124 (1) , 25-29
Open AccessFetal Airway Wound Repair
SCARRING IS an important medical problem that may lead to poor cosmesis, structure, function, and growth. Otology, laryngology, and bronchoesophagology all have mucosa as their primary building block. Aberrant mucosal wound healing in the middle ear results in conductive hearing loss, eustachian tube dysfunction, adhesive otitis media, tympanosclerosis, and other abnormalities. In the airway, the consequences of scarring are potentially more devastating. The development of nasal, nasopharyngeal, laryngotracheal, and esophageal stenosis may be life threatening. Subglottic stenosis in children, for example, has become increasingly prevalent during the past quarter century because of widespread use of prolonged endotracheal intubation for respiratory support.1 Mortality rates as high as 24%, directly attributable to the tracheostomy in these children, have been reported.2 Not life threatening but, nonetheless, a priority to otolaryngologists are the perturbations in speech and communication caused by laryngeal scarring. Prevention or reduction of scarring remains a major goal of otolaryngologists.